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Abstract
Point mutations in peripherin-2 (PRPH2) are associated with severe retinal degenerative
disorders affecting rod and/or cone photoreceptors. Various disease-causing mutations
have been identified, but the exact contribution of a given mutation to the clinical phenotype
remains unclear. Exonic point mutations are usually assumed to alter single amino acids,
thereby influencing specific protein characteristics; however, they can also affect mRNA
splicing. To examine the effects of distinct PRPH2 point mutations on mRNA splicing and
protein expression in vivo, we designed PRPH2 minigenes containing the three coding
exons and relevant intronic regions of human PRPH2. Minigenes carrying wild type PRPH2
or PRPH2 exon 2 mutations associated with rod or cone disorders were expressed in
murine photoreceptors using recombinant adeno-associated virus (rAAV) vectors. We
detect three PRPH2 splice isoforms in rods and cones: correctly spliced, intron 1 retention,
and unspliced. In addition, we show that only the correctly spliced isoform results in detect-
able protein expression. Surprisingly, compared to rods, differential splicing leads to lower
expression of correctly spliced and higher expression of unspliced PRPH2 in cones. These
results were confirmed in qRT-PCR experiments from FAC-sorted murine rods and cones.
Strikingly, three out of five cone disease-causing PRPH2 mutations profoundly enhanced
correct splicing of PRPH2, which correlated with strong upregulation of mutant PRPH2 pro-
tein expression in cones. By contrast, four out of six PRPH2 mutants associated with rod
disorders gave rise to a reduced PRPH2 protein expression via different mechanisms.
These mechanisms include aberrant mRNA splicing, protein mislocalization, and protein
degradation. Our data suggest that upregulation of PRPH2 levels in combination with
defects in the PRPH2 function caused by the mutation might be an important mechanism
PLOSGenetics | DOI:10.1371/journal.pgen.1005811 January 21, 2016 1 / 22
OPEN ACCESS
Citation: Becirovic E, Böhm S, Nguyen ONP,
Riedmayr LM, Koch MA, Schulze E, et al. (2016) In
Vivo Analysis of Disease-Associated Point Mutations
Unveils Profound Differences in mRNA Splicing of
Peripherin-2 in Rod and Cone Photoreceptors. PLoS
Genet 12(1): e1005811. doi:10.1371/journal.
pgen.1005811
Editor: Anand Swaroop, National Eye Institute,
UNITED STATES
Received: August 27, 2015
Accepted: December 22, 2015
Published: January 21, 2016
Copyright: © 2016 Becirovic et al. This is an open
access article distributed under the terms of the
Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any
medium, provided the original author and source are
credited.
Data Availability Statement: All relevant data are
within the paper and its Supporting Information files.
Funding: This work was funded by the Deutsche
Forschungsgemeinschaft, grant number BE 4830/1-
1. The funders had no role in study design, data
collection and analysis, decision to publish, or
preparation of the manuscript.
Competing Interests: The authors have declared
that no competing interests exist.
leading to cone degeneration. By contrast, the pathology of rod-specific PRPH2 mutations
is rather characterized by PRPH2 downregulation and impaired protein localization.
Author Summary
Photoreceptors are the light sensing cells of the retina and consist of dim light and night
vision mediating rods and daylight and color vision mediating cones. PRPH2 is crucial for
the structural and functional integrity of photoreceptors. Some point mutations in PRPH2
lead to degeneration of rods, whereas others only affect cones. We examined the potential
effects of 11 disease-linked PRPH2 mutations on mRNA splicing and protein expression
in vivo. For this, we expressed six PRPH2 mutants associated with degeneration of rods in
murine rods and five additional mutants linked to cone diseases in murine cones. We
demonstrate that different splicing efficiencies of PRPH2 lead to its high expression in
rods and to its low expression in cones. Furthermore, we show that the majority of PRPH2
mutants associated with cone disorders results in an upregulation of PRPH2 expression in
cones by increasing the mRNA splicing efficiency. By contrast, the majority of PRPH2
mutants associated with rod diseases leads to a downregulation of PRPH2 expression in
rods via different mechanisms including aberrant mRNA splicing. These results provide
novel insights into the pathobiology of mRNA splicing in photoreceptors and might con-
tribute to explain the differential penetrance of PRPH2 mutants in rods and cones.
Introduction
The retina converts light into electrical signals via two highly specialized types of neurons, rod
and cone photoreceptors. Both types of photoreceptors express in their light-sensitive outer
segments (rod outer segments, ROS and cone outer segments, COS, respectively) a specific
member of the tetraspanin protein family, peripherin-2 (PRPH2). PRPH2 is a glycosylated pro-
tein harboring four transmembrane helices and was found to be crucial for development and
structural integrity of photoreceptor outer segments [1, 2]. Mutations in the human PRPH2
gene are linked to retinal disorders affecting the structure or function of rods or cones. Some of
these mutations lead to autosomal dominant retinitis pigmentosa (adRP), a degenerative dis-
ease that primarily affects the rod photoreceptors, whereas others result in different types of
autosomal dominant disorders characterized by cone defects [3]. The molecular pathways
underlying the rod vs cone specificity of individual PRPH2 mutations are currently unknown.
The vast majority of PRPH2 mutations are point mutations and many of them are located in
exon 2, which encodes for the distal half of the loop domain connecting the third and fourth
transmembrane segment (D2 loop), and the proximal half of the fourth transmembrane
domain. Previous studies demonstrated that disease-associated exonic point mutations can
affect regulatory elements of mRNA splicing via different mechanisms [4]. These mechanisms
include the abolition of existing or generation of novel donor or acceptor sites [4, 5]. Alterna-
tively, exonic point mutations may also affect the binding motifs of so-called exonic splice
enhancers (ESEs) or exonic splice silencers (ESSs) [6, 7]. These binding motifs usually comprise
4–18 nucleotides and regulate constitutive and alternative splicing [8, 9]. Point mutations that
alter existing or generate novel binding sites for ESEs or ESSs can either lead to skipping of the
respective exon or to the retention of flanking introns [4, 8, 10]. Moreover, differential splicing
occurs in a highly cell-specific manner [11] highlighting the need to analyze splicing defects in
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the cell type of interest (e.g. rod or cone photoreceptor). A high number of disease-linked
exonic point mutations have been identified in genes known to be crucial for the functional
and structural identity of photoreceptors (https://sph.uth.edu/retnet/disease.htm). However,
the potential effects of these point mutations on mRNA splicing in their native environment
have not been examined for any of these genes so far. Moreover, studies addressing the effects
of exonic point mutations on regulatory splicing elements were performed on minigenes that
do not cover the full-length coding sequence and, hence, do not permit concomitant analysis of
how the mutations affect protein expression [12]. However, side-by-side analysis of protein
expression is essential to dissect the mechanisms leading to diseased states. To examine the
impact of exonic PRPH2 point mutations on splicing and protein expression in photorecep-
tors, we constructed rAAV vectors that express PRPH2 minigenes containing native canonical
splice sites and all three coding exons of PRPH2 under control of either a rod or a cone specific
promoter. Using this approach, we unravel cell type- and mutation-specific differential mRNA
splicing as a novel mechanism regulating PRPH2 protein expression in healthy and diseased
rod and cone photoreceptors.
Results
rAAV-PRPH2 minigenes confer efficient expression of PRPH2 in rods
and cones
The entire human PRPH2 gene including the 5’ and 3’ untranslated region, the exons, and the
introns encompasses approximately 26 kb (Fig 1A, upper panel). Consequently, with regard to
the limited capacity of the rAAV vectors [13], splicing cannot be analyzed on the native
PRPH2 transcript. In an attempt to study PRPH2 splicing in rod and cone photoreceptors, we
deleted most of the intronic sequences with the exception of 180–200 bp flanking the exons
and the 5’ end of the PRPH2 gene (Fig 1A, lower panel). This construct was fused to a citrine
tag to allow monitoring of minigene-derived PRPH2 expression. The resulting construct was
inserted in the rAAV vector containing either a human rhodopsin (i.e. rod-specific) or murine
short wavelength opsin (i.e. cone-specific) promoter yielding minigene vectors rP-mg and cP-
mg, respectively (Fig 1B). Correct splicing of these minigenes leads to an N-terminally citrine-
tagged PRPH2 with a molecular weight of approx. 66.5 kDa (Fig 1C). rP-mg and cP-mg were
packaged as AAV2/8 Y733F viral particles [13, 14] and delivered into the subretinal space of
two week old (P14) wild type mice. Subsequent analysis of minigene-derived PRPH2 expres-
sion was monitored three weeks post injection by citrine fluorescence on retinal slices from
injected animals. In both, ROS and COS, citrine was exclusively expressed in the outer seg-
ments (Fig 1D and 1E).
In silicomRNA splice analysis of exon 2-specific PRPH2 point mutations
Exon 2 of PRPH2 represents a mutational hotspot and encodes for the distal part of the D2
loop domain and for the proximal half of transmembrane domain 4 (S1 Fig). Initially, we per-
formed in silico prediction of the potential effects of 30 exon 2-specific PRPH2 point mutations
on aberrant mRNA splicing using the ASSEDA and NNSplice splice prediction software. For
in silico prediction, we used 40 bp sequences flanking the respective mutation from each site.
This analysis provided a variety of predicted effects on mRNA splicing for many mutants
including the potential generation of novel donor or acceptor sites and the abolition or genera-
tion of binding sites for ESEs or ESSs (S1 Table). To test the potential differences of PRPH2
mutants on mRNA splicing experimentally, we randomly chose eleven point mutants predicted
to impact splicing from the in silico analysis. Six of these mutants are associated with
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autosomal-dominant retinitis pigmentosa (adRP), the most common type of inherited autoso-
mal-dominant degenerative retinal disorders, whereas five are found in patients suffering from
Fig 1. Design and in vivo expression of PRPH2minigenes. (A) Exon-intron structure of native human PRPH2 (upper panel) and derived PRPH2minigene
used in this study (lower panel). In the minigene, intron 1 and intron 2 were largely deleted with the exception of sequences flanking exons 1–3 as indicated.
(B) PRPH2minigene constructs containing different promoters used for the analysis in rods (rP-mg; top), and cones (cP-mg; bottom). hRHO, human
rhodopsin promoter; mSWS, murine S-opsin promoter. To allow antibody-free visualization of minigene-derived PRPH2, a citrine tag was fused to exon 1 (N-
terminus) of PRPH2. (C) Topology of the correctly spliced citrine-tagged PRPH2. N- and C-termini face the intracellular side of photoreceptors. By contrast,
the D2 loop is located on the intradiskal (rods) or extracellular (cones) side (cf. S1 Fig). (D and E) Immunohistology of murine retinas injected on P14 with rP-
mg (D) and cP-mg (E), respectively. Retinas were harvested three weeks post injection. Scale bar represents 20 μm. CNGB1a (B1a) and M-opsin (M-ops)
antibodies were employed to label rod and cone outer segments, respectively.
doi:10.1371/journal.pgen.1005811.g001
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different types of cone diseases (Table 1). None of these mutants have been previously analyzed
for their potential effects on mRNA splicing.
Comparative splice analysis of wild type and mutant PRPH2 minigenes
in rods and cones
We analyzed the mRNA splicing of the PRPH2 point mutants using RT-PCR performed with
minigene-specific primers and compared the pattern of the splice products after rod- or cone-
specific expression, respectively (Fig 2A). For this purpose, wild type (WT) mice were injected
at P14 with WT or respective mutant PRPH2 constructs. Three weeks after injection, RNA was
isolated and pooled from four retinas of four injected animals. The identity of transcripts was
confirmed by direct sequencing of the purified amplicons (S2 Fig). Three different splice prod-
ucts were obtained for WT and mutant PRPH2 minigenes in rods and cones. These three splice
products corresponded to i) the unspliced variant containing both introns, ii) the splice variant
with retained intron 1, and iii) the correctly spliced PRPH2. The adRP-associated G249Smuta-
tion gave rise to a fourth splice variant that contained an in-frame deletion of 90 bp at the 3’
end of exon 2 caused by the use of a novel donor site (DS) (Fig 2A and 2B). However, the most
intriguing finding was that, other than in rods, the unspliced PRPH2 transcript was the most
prominent splice isoform in cones and the correctly spliced PRPH2 transcript was present at
lower amounts in this cell type (Fig 2A).
Semi-quantitative analysis of the PRPH2 splice isoforms
For quantification of the three PRPH2 splice variants (unspliced, intron 1 retention, and cor-
rectly spliced), we injected mice at P14 with rAAVs expressing WT or mutant PRPH2 mini-
genes and isolated the RNA three weeks post injection. For RT-PCR experiments, we used
RNA isolated from a set of four injected retinas pooled for each WT or mutant construct. To
determine the linear range of amplification, we performed quantitative RT-PCR (qRT-PCR)
from mice injected with WT PRPH2 in rods and cones using primers as indicated in Fig 2B.
Linear range of amplification was between 20–28 cycles for rods and between 26–33 cycles for
cones, respectively (S3 Fig). Subsequently, five technical RT-PCR replicates were conducted
using a variable number of cycles falling within the respective range of linear amplification in
Table 1. Point mutations in exon 2 of PRPH2 analyzed in this study [15–25].
Mutation Disease References
c.584G>T; p.R195L cone and cone-rod dystrophy Yanagihashi et al. 2003
c.594C>G; p.S198R adRP Sullivan et al. 2006
c.625G>A; p.V209I adult foveomacular vitelliform dystrophy Coco et al. 2010
c.629C>T; p.P210L adRP Budu et al. 2001
c.635G>C; p.S212T adult foveomacular vitelliform dystrophy Felbor et al. 1997
c.641G>C; p.C214S adRP Saga et al. 1993
c.658C>T; p.R220W pattern dystrophy Payne et al. 1998
c.659G>A; p.R220Q pattern dystrophy Jacobson et al. 1996
c.676C>G; p.Q226E adRP Rodriguez et al. 1994
c.736T>C; p.W246R adRP Kohl et al. 1997
c.745G>A; p.G249S adRP Renner et al. 2009
Six mutations lead to autosomal dominant retinitis pigmentosa (adRP) and ﬁve mutations are linked to cone
diseases.
doi:10.1371/journal.pgen.1005811.t001
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rods and cones. We calculated the mean percentage of unspliced, intron 1 retention, and the
correctly spliced transcripts relative to the sum of band intensities for all PRPH2 minigenes.
The data analysis revealed profound differences in the relative percentage of the single splice
isoforms in rods and cones, respectively. These differences were observed when comparing the
splicing of WT PRPH2 minigenes in rods and cones, but also when relating the effects of the
single mutants to the corresponding WT in a given cell type. For WT PRPH2 in rods, the
major splice isoform was the correctly spliced transcript (approx. 70%), whereas splicing of
WT PRPH2 in cones yielded only low amounts of this PRPH2 isoform (approx. 2%, Fig 2E and
Table 2). By contrast, in cones, splicing of WT PRPH2 predominantly resulted in the unspliced
Fig 2. Splice analysis of PRPH2WT andmutant minigenes in rods and cones. (A) Representative RT-PCR from cDNA generated from total RNA three
weeks post injection from retinas injected with wild-type and mutant rP-mg (left) or cP-mg (right) on P14. Ctrl, control containing the cDNA from non-
transduced retina. The single bands of the relevant splice products are numbered (1–4) and highlighted by arrowheads. (B) Schematic representation of the
detected splice variants using primers binding to the 3’-end of citrine and to the 5’-end of exon 3 as indicated by the arrows. The numbers of the constructs
correspond to the bands marked in (A). (C-E) Semi-quantitative analysis of the relative intensities of the unspliced (C), intron 1 retention (D), and correctly
spliced (E) PRPH2 transcripts. For each PRPH2minigene, the mean percentage of the intensities of these three variants relative to the total intensity (given
as sum of the single intensities) was calculated from five RT-PCR analyses conducted with a variable number of cycles (25–27 for rods and 30–32 for cones,
respectively). Significance test of the rod or cone mutants to the corresponding wild type (one-way ANOVA followed by Dunett’s test) was performed for rP-
mg and cP-mg, respectively. All data were shown as mean values and the error bars represent the standard error of the mean (SEM). *, p< 0.05; **, p< 0.01;
***, p< 0.001. DS, splice donor site.
doi:10.1371/journal.pgen.1005811.g002
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isoform (87%, Fig 2C). A moderate difference between WT PRPH2 in rods and cones could be
observed for the intron 1 retention isoform (22% in rods vs 11% in cones, Fig 2D). Next, we
compared the relative percentages of splice bands for single PRPH2 mutants to the respective
WT expressed in rods and cones. No variability in the percentage of the intron 1 retention iso-
form was observed for any of the mutants in rods and cones (Fig 2D). However, the amount of
the correctly spliced isoform was reduced to 51% for the G249S rod-dominant mutation (Fig
2E and Table 2). This reduction most likely results from the generation of the novel donor site
observed for this mutant. By contrast, in cones, three mutants (V209I, R195L, and R220Q)
resulted in a strong increase in the percentage of the correctly spliced PRPH2 isoform, which
was accompanied by an appropriate decrease in the unspliced transcript (Fig 2C and 2E and
Table 2). Taken together, these results indicate cell-type and mutation specific effects on
mRNA splicing of PRPH2 in rods and cones.
Quantitative analysis of native PRPH2 splice isoforms
The experiments shown in Fig 2A were performed using minigenes that contain human
PRPH2 expressed in murine photoreceptors. However, it is conceivable that endogenous abun-
dance of the single PRPH2 splice isoforms might differ in human and in mouse photorecep-
tors, which in turn would impede the interpretation of our minigene-based assay. To examine
if murine photoreceptors are suitable for the splicing analysis of human PRPH2, we investi-
gated the endogenous levels of PRPH2 splice isoforms in human and murine retina using
qRT-PCR. To this end, we utilized two specific primer sets amplifying the two human or
murine PRPH2 transcripts mirroring the splice isoforms obtained in the minigene experiments
(Fig 3A). Specific amplification of the unspliced PRPH2 transcript was assessed using primers
binding to the intronic regions flanking exon 2 (P-us_F and P-us_R). To detect the correctly
spliced PRPH2 isoform, we used primers binding to exon 1 and exon 3 (P-cs_F and P-cs_R).
Due to the large size of the interjacent native introns (23 kb for human and 12 kb for murine
intron 1 and intron 2, respectively, cf. Fig 1A and Fig 3A), PRPH2 isoforms bearing the introns
Table 2. Relative intensity percentages of PRPH2 isoforms for WT andmutant PRPH2minigenes in rods and cones.
C214S P210L S198R Q226E W246R G249S WT V209I R195L R220Q S212T R220W WT
unspliced MV 7.48 6.79 6.17 6.41 7.22 8.53 7.54 65.01 57.95 46.21 84.74 86.68 87.09
SEM 1.00 1.85 1.25 1.43 1.70 1.84 1.19 2.25 1.60 2.86 1.78 1.24 1.12
Dunett's
test
n.s. n.s. n.s. n.s. n.s. n.s. n.s. n.s. n.s. n.s. n.s.
intron 1
retention
MV 25.60 24.15 25.25 22.81 23.66 25.73 22.35 14.52 14.94 17.33 13.00 11.31 11.27
SEM 3.40 2.15 2.38 2.99 1.77 2.64 2.26 1.38 1.26 1.50 1.97 0.95 1.06
Dunett's
test
n.s. n.s. n.s. n.s. n.s. n.s. n.s. n.s. n.s. n.s. n.s.
correctly
spliced
MV 66.92 69.05 68.57 70.78 69.13 56.19 70.11 20.47 27.10 36.46 2.25 2.01 1.64
SEM 2.65 3.21 3.09 4.16 3.39 1.31 2.09 1.59 2.04 2.89 0.39 0.43 0.42
Dunett's
test
n.s. n.s. n.s. n.s. n.s. p<0.05 p<0.0001 p<0.0001 p<0.0001 n.s. n.s.
MV, mean value
SEM, standard error of the mean.
n.s., not signiﬁcant.
doi:10.1371/journal.pgen.1005811.t002
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Fig 3. Quantification of PRPH2 splice isoforms in native human andmurine photoreceptors. (A) True-to-scale representation of the exonic and intronic
regions of human PRPH2 (upper panel) and mouse Prph2 (lower panel). The binding positions of primers used for qRT-PCR are indicated by arrows. For
correctly spliced human PRPH2 or murine Prph2 (hP-cs or mP-cs), the P-cs_F and P-cs_R primer combination was used. For detection of the unspliced
human (hP-us) or murine (mP-us) variant, the P-us_F and P-us_R primer combination was applied. (B) qRT-PCR from pooled human (gray boxes) or mouse
(black boxes) total retinal RNA isolated from two (human) or four (mouse) biological samples. The single values are as follows: hP-cs, 10.60 ± 0.67; hP-us,
0.21 ± 0.03; mP-cs, 5.60 ± 0.29; mP-us, 0.13 ± 0.03. All data are given as mean values and error bars represent the SEM. Three technical replicates were
conducted for each primer combination and the expression was normalized to the housekeeper aminolevulinic acid synthase (ALAS). (C) Relative ratios
given as mean values ± SEM of the single unspliced transcripts to the corresponding correctly spliced isoform from human (0.10 ± 0.01) or mouse
(0.13 ± 0.02) retina. Significance test was performed with the two-tailed t-test (p = 0.26). (D) qRT-PCR analysis from sorted murine rods (red boxes) and
cones (black boxes), respectively. For qRT-PCR, cDNA resulting from pooled rods sorted from six animals (yielding 100.000 cells) and pooled cones sorted
from four animals (yielding 27.000 cells) were used. cDNA synthesis was performed using identical total RNA concentration for rods and cones, respectively
(50 ng each). For purity assessment of FAC-sorted rods and cones, primers specific for murine rhodopsin (Rho) and M-opsin (Opn1mw) were used. For
detection of Prph2 splice isoforms, the same primer combinations were applied as indicated in Fig 3A. Three technical replicates were conducted for each
primer combination and the expression was normalized to the housekeeper aminolevulinic acid synthase (Alas). All data are given as mean values and error
bars represent the SEM. The single values for FAC-sorted rods are as follows: Rho, 146.90 ± 10.24; Opn1mw, 1.25 ± 0.16; P-cs, 16.67 ± 0.71; P-us, ±
0.95 ± 0.07. Expression in sorted cones yielded following values: Rho, 5.27 ± 0.14; Opn1mw, 6.38 ± 0.13; P-cs, 5.45 ± 0.44; P-us, ± 2.71 ± 0.19. P-cs rods vs
cones: p = 0.0002; P-us rods vs cones: p = 0.001. (E) Relative ratios of the single unspliced transcripts to the corresponding correctly spliced isoform from
FAC-sorted rods or cones. Significance analysis was performed with the two-tailed t-test (p = 0.0003).
doi:10.1371/journal.pgen.1005811.g003
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are most likely not amplified under the qRT-PCR conditions. For quantification, the relative
expression of all single isoforms was normalized to the endogenous housekeeper aminolevuli-
nic acid synthase (ALAS). Importantly, both primer combinations led to clearly detectable
qPCR products in both, human and mouse retina with the relative PRPH2 expression being
slightly higher for both combinations in the human retina (Fig 3B). Of note, given the fact that,
in human and mouse retina, rods account for>95% of the photoreceptor population, the
expected results should reflect the splicing of PRPH2 minigenes in rods. In line with this, we
found the correctly spliced PRPH2 isoform to be much higher expressed in native retina when
compared to the unspliced variant (10.60 ± 0.68 vs 0.21 ± 0.03 for human, and 5.60 ± 0.29 vs
0.14 ± 0.03 for murine retina, respectively). No differences between human and mouse PRPH2
expression could be detected when plotting the ratio of the unspliced to the corresponding cor-
rectly spliced PRPH2 isoforms (0.10 ± 0.01 for human vs 0.13 ± 0.02 for murine retina, respec-
tively (Fig 3C)). Taken together, these results strongly indicate that in both, qualitative and
quantitative terms, splicing of PRPH2 is very similar in the human and the mouse retina.
Our PRPH2 minigene results revealed that cones significantly differ from rods in relative
abundance of the correctly spliced and the unspliced PRPH2 variants (Fig 2A). To test if this
also holds true in the native context, we purified rods and cones from 6–8 weeks old mice by
fluorescence-activated cell sorting (FACS) and subsequently determined the abundance of
endogenous murine Prph2 splice isoforms in sorted photoreceptors [26, 27]. The purity of
sorted photoreceptors was validated by assessing the transcript levels of the cell type-specific
genes rhodopsin (Rho) and M-opsin (Opn1mw) as markers for rods and cones, respectively.
Compared to the FAC-sorted rods, sorted cones displayed a 28-fold reduction of Rho expres-
sion accompanied by a 5-fold increase of M-opsin expression (Fig 3D). This indicates a high
purity of sorted cones showing only a slight contamination with rods (about 3.6%). In line with
the qRT-PCR results shown in Fig 3B for the native retina, in FAC-sorted rods, we found the
correctly spliced Prph2 isoform to be much higher expressed when compared to the unspliced
variant (16.67 ± 0.71 vs 0.95 ± 0.07, Fig 3D). By contrast, in FAC-sorted cones, the expression
of correctly spliced Prph2 displayed only a very moderate increase compared to the unspliced
variant (5.45 ± 0.44 vs 2.71 ± 0.19). Concomitantly, these data also demonstrate that the rela-
tive expression of correctly spliced Prph2 was decreased in cones, which was accompanied by
an increase in the expression of the unspliced Prph2 transcript. These differences in expression
of the single Prph2 isoforms between rods and cones become even more obvious when com-
paring the ratios of the unspliced to the correctly spliced Prph2 isoforms between the two cell
types (0.06 ± 0.004 for rods and 0.49 ± 0.04 for cones, respectively (Fig 3E)). Taken together,
these data are largely compatible with the data observed from our minigenes and show that the
relative endogenous levels of correctly spliced and unspliced Prph2 isoforms differ significantly
between rods and cones.
PRPH2 isoform encoded by exon 1 is mislocalized in photoreceptors
Results shown in Fig 1D and 1E indicate that minigene-derived, fluorophore-tagged PRPH2
protein is correctly expressed and localized in murine rod and cone outer segments. However,
since all minigene-derived PRPH2 splice isoforms bear the fluorophore, the detection of the
fluorophore signal does not allow to discriminate which of these isoforms are expressed on
protein level. The correctly spliced, fluorophore-tagged PRPH2 leads to the full-length protein
known to be properly localized in the outer segments [28]. However, the remaining two
PRPH2 splice isoforms (unspliced and intron 1 retention) harbor a premature stop codon
immediately after exon 1 and their expression was not analyzed in previous studies. Transla-
tion of these two PRPH2 transcripts would result in a truncated PRPH2 protein lacking the
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distal half of the D2 loop, TM4, and downstream sequence (Fig 4A and S2 Fig panel C). With
respect to the translation and protein expression of these PRPH2 isoforms, one can in principle
assume four different possibilities: i) The two splice isoforms are translated into protein and
the protein is stable, but mislocalized to the inner segments. ii) The two splice isoforms are
translated into protein and the protein is correctly localized. iii) They are translated into pro-
tein, but the protein is degraded. iv) They are not translated into protein, but are degraded on
mRNA level, i.e. via the nonsense-mediated mRNA decay (NMD) mechanism, which requires
the presence of a premature stop codon within the mRNA. The first possibility can be excluded
since we do not observe any mislocalized protein in transduced photoreceptors upon expres-
sion of the WT PRPH2 minigene. To discriminate between the remaining three scenarios we
expressed the PRPH2 variant that harbors a stop codon immediately after exon 1 and, there-
fore, mirrors the protein that is translated from the unspliced or intron 1 retention transcript
(cf. S2 Fig panel C). However, in contrast to the two minigene-derived PRPH2 splice isoforms,
this variant does not contain a premature stop codon and, thus, the mRNA cannot be degraded
via the NMDmechanism. Expression of the truncated PRPH2 in rod or cone photoreceptors
leads to a protein that is highly expressed, but is completely mislocalized to the inner segments
(Fig 4B and 4C). Thus, scenario ii) or iii) proposing correctly localization or protein degrada-
tion of this PRPH2 isoform could be excluded. Based on these findings, we conclude that the
two splice isoforms harboring a premature stop codon are not translated into protein, presum-
ably due to mRNA degradation via the NMDmechanism.
Protein expression and localization of PRPH2 mutants in rods and
cones
We next used PRPH2 minigene rAAV vectors to analyze the protein expression and retinal
localization of PRPH2 mutants linked to cone diseases (Fig 5). All five mutants produced sig-
nificant levels of proteins that were correctly localized to the cone outer segments (Fig 5A–5E).
In Western blot analysis, the mutant proteins migrated at the size of the wild type full-length
PRPH2 (approx. 66.5 kDa), however, expression levels differed between the various mutant
and the wild type protein (Fig 5F). In particular, we detected a robust increase in protein
Fig 4. Impaired targeting of truncated PRPH2. Immunohistology of transduced murine retinas showing rod- (B) and cone-specific (C) expression of a
truncated version of PRPH2. (A) Truncated PRPH2 contains only exon 1 and a downstream stop codon (indicated by “X”) mimicking translation from
unspliced PRPH2mRNA and PRPH2mRNA with intron 1 retention. Staining for B1a and M-ops was used to label rod and cone photoreceptors, respectively.
Truncated PRPH2 is not transported to outer segments and is almost exclusively present in inner segments and somata of photoreceptors. Scale bar
represents 20 μm.
doi:10.1371/journal.pgen.1005811.g004
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Fig 5. Retinal expression of PRPH2mutants linked to cone diseases. (A-E) Immunohistological analysis
of retinas transduced with the PRPH2minigenes carrying single point mutations under the control of the
mSWS promoter as indicated. Scale bar represents 20 μm. (F) Western blot analysis frommembrane
preparations of murine retinas transduced with the PRPH2minigenes shown in A-E. Western blotting was
conducted using four pooled retinas from four animals injected on P14. All retinas were collected three weeks
post injection. Ctrl, protein lysates from non-injected control retinas. PRPH2 was detected by an anti-GFP
mRNA Splicing of Peripherin-2 in Rods and Cones
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expression for the V209I, R195L, and R220Qmutants compared to the WT PRPH2 (Fig 5F and
5G). These findings are in line with the strongly increased splicing efficiency of these three
mutants resulting in higher levels of correctly spliced PRPH2 in cones (cf. Fig 2). In contrast to
uniform behavior of "cone-specific" PRPH2 mutations, "rod-specific" PRPH2 mutants linked
to adRP revealed more diverse effects. In particular, for the C214Smutant, whose effect on pro-
tein localization was also previously investigated [29], we confirmed a severe protein mislocali-
zation to the inner segment and throughout the photoreceptor cell (Fig 6A). Similar to C214S,
we found that also the P210Lmutant results in massive mislocalization to the inner segment
(Fig 6B). However, in contrast to the C214Smutant that showed an evenly cytosolic distribu-
tion pattern, the P210Lmutant was found in large and speckled vesicular-like structures. In
addition to these findings, the Western blot analysis revealed a more or less pronounced reduc-
tion of protein expression for four adRP-linked PRPH2 mutations (Fig 6G and 6H). The stron-
gest reduction was observed for the C214S and for the S198Rmutant, followed by the P210L
and the G249Smutation. By contrast, the other two analyzed mutants resulted in wild type-like
protein levels (Fig 6G and 6H). Interestingly, two of the mutants (S198R and P210L) displayed
an additional approx. 42 kDa band on the Western blot most likely resulting from protein deg-
radation. Such degradation was described for mutations causing protein misfolding, which
could lead to the accessibility for a specific protease cleavage site that is hidden in the native
protein. The 42 kDa band could not be detected for the C214S and for the G249Smutation sug-
gesting that distinct mechanisms might cause the reduced protein levels of these PRPH2
mutants. The moderate decrease of protein expression of the G249Smutant is probably caused
by a reduction of the relative amount of the correctly spliced PRPH2 transcript due to the gen-
eration of a novel donor splice site, as shown in Fig 2A. Accordingly, the resulting G249S
mutant protein bears a deletion of 30 amino acids covering the most distal part of the D2 loop
domain and the proximal half of transmembrane domain 4 (Fig 2B and S2 Fig panel B). This
deletion is expected to result in a 3.5 kDa shift leading to a calculated molecular mass of 63
kDa. However, no band for the G249Smutant was detected at this molecular weight indicating
that the aberrantly spliced isoform is degraded either at the mRNA or at the protein level. In
summary, despite the remarkable variability of the single disease mechanisms observed for
four of the six adRP associated mutants described above, their most common feature is that
they all lead to a reduction of protein expression in outer segments of rods. Of note, differences
in protein expression shown in Fig 5G and Fig 6H might also result from the individual differ-
ences in the size of the injection areas or from differences in viral transduction efficiencies
between the constructs. To exclude these possibilities, we performed two sets of experiments.
First, using fundus photography, we show that the size of the injected areas was comparable for
the single mutants and the WT PRPH2 in rods and cones always covering approx. 1/3 of the
complete retina (S4 Fig). Second, we reasoned that potential differences in transduction effi-
ciencies should also lead to differences in the sum of the single transcript intensities between
the PRPH2 minigenes obtained from RT-PCR analysis. However, no substantial variability
could be detected when comparing the sum of band intensities for the single PRPH2 constructs
in rod or cones (S5 Fig). Hence, we conclude that the differential effects of the single PRPH2
mutants on protein expression reflect intrinsic properties of the mutants and are most likely
not caused by technical issues.
antibody that recognized the citrine tag. As loading control, an antibody against the murine alpha subunit of
ATPase was used (anti-ATPase). (G) Semi-quantitative analysis of the results shown in (F). For
quantification, three technical replicates were conducted and PRPH2 expression was normalized to the
ATPase expression. All data are given as mean values ± SEM. Statistical analysis was performed using one-
way ANOVA followed by the Dunett’s test. *, p< 0.05; **, p< 0.01; ***, p< 0.001. n.s., not significant.
doi:10.1371/journal.pgen.1005811.g005
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Splicing and protein expression of a rod-dominant PRPH2 mutant in
cones and a cone-dominant mutant in rods
So far, analysis of splicing and protein expression of PRPH2 mutations associated with rod or
cone defects was exclusively conducted in the photoreceptor type reported to be affected by the
given mutation. To exclude the possibility that mutations also influence splicing or protein
expression in the photoreceptor type that is primarily not impaired by the mutation, we
expressed the rod-dominantW246Rmutation in cones and the cone-dominant R220Wmutant
in rods, respectively. However, protein localization, splicing, and protein expression levels of
both mutants appeared normal and were indistinguishable from the corresponding wild type
(S6 Fig).
Discussion
In this study, using minigenes expressing humanWT and eleven PRPH2 point mutants in
murine photoreceptors, we uncover a novel role of mRNA splicing on PRPH2 protein expres-
sion in rods and in cones. RT-PCR based analysis of PRPH2 transcripts in murine retinas
transduced with the PRPH2 minigenes identified three different PRPH2 splice isoforms in
rods and cones. These splice isoforms comprise the unspliced transcript, the intron 1 retention,
and the correctly spliced PRPH2. Importantly, we confirmed the existence of the unspliced iso-
form by qRT-PCR from native human and murine retina and FAC-sorted murine rods and
cones. Furthermore, analysis of the relative abundance of unspliced and correctly spliced
PRPH2 isoforms in sorted rods and cones suggests that, compared to rods, cones express lower
amounts of the correctly spliced and higher amounts of the unspliced PRPH2 transcript. In
addition, we reveal that only the correctly spliced isoform was translated into protein, whereas
the remaining two splice isoforms were probably degraded on mRNA level. This indicates that
in cones, alternative mRNA splicing might represent a mechanism that has evolved to keep
PRPH2 protein expression rather low. Currently, one only may speculate why cones are anx-
ious for lower amounts of PRPH2 and long-term studies (e.g. in knock-in animals carrying the
respective cone-dominant mutants) are required to elucidate the exact function of differential
expression levels of PRPH2 in photoreceptors. A comparison of the splicing pattern and pro-
tein expression of the PRPH2 mutants in rods and cones revealed a novel genotype-phenotype
correlation (Table 3). Three of five mutants associated with cone disorders resulted in a robust
increase in the relative amount of the correctly spliced PRPH2 transcript compared to the WT
in cones. This increase in mRNA splicing efficiency was accompanied by an increase in protein
expression as seen in immunostaining and Western blotting from transduced retinas. None of
the cone-dominant PRPH2 mutants affected protein localization or protein expression pattern.
In a previous study, it was shown that a very moderate overexpression of PRPH2 in cones
(50%) does not affect their morphology and function [30]. However, our results imply that
some PRPH2 point mutants can trigger very profound overexpression that may well exert
Fig 6. Protein expression of PRPH2mutants linked to adRP. (A-F) Immunohistology of retinas
transduced with PRPH2minigenes containing single point mutations as indicated under the control of the
hRHO promoter. Scale bar represents 20 μm. (G) Western blot analysis frommembrane preparations of four
pooled murine retinas from four animals transduced with the PRPH2minigenes shown in (A-F) on P14. All
retinas were collected three weeks post injection. The arrowhead indicates a degradation band detected at
42 kDa. Ctrl, protein lysates from non-injected control retinas. (H) Semi-quantitative analysis of the results
shown in (G). For quantification, three technical replicates were conducted and PRPH2 expression was
normalized to the ATPase expression. All data are given as mean values and error bars represent the SEM.
Statistical analysis was performed using one-way ANOVA followed by the Dunett’s test. *, p< 0.05; **, p<
0.01; ***, p< 0.001. n.s., not significant.
doi:10.1371/journal.pgen.1005811.g006
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detrimental effects on cones. Two of the cone-dominant PRPH2 mutants (S212T and R220W)
analyzed herein did not show any effects on splicing and protein expression. This suggests that
protein overexpression is not an universal mechanism sufficient to explain the penetrance of
all cone disease-linked PRPH2 mutants. In line with this, a recent study analyzing another
cone disease-linked D2 loop mutation in PRPH2 (R172W) revealed detrimental effects of this
mutation on cones without affecting the protein expression [31]. Further studies are necessary
to determine whether protein overexpression on its own, a functional defect caused by the
PRPH2 mutation, or a combination of both mechanisms underlie the observed disease
phenotype.
In contrast to PRPH2 mutants in cones, four out of six adRP-linked mutants led to a reduc-
tion of protein expression in outer segments of rods via different mechanisms. These mecha-
nisms include aberrant mRNA splicing, protein mislocalization, and protein degradation
(Table 3). The only mutant affecting the mRNA splicing in rods was the G249Smutation. This
mutant results in the generation of a novel donor site in exon 2, thereby reducing the expres-
sion relative to the correctly spliced PRPH2 by approximately 20%. Notably, only the correctly
spliced PRPH2 was expressed on protein level, whereas the remaining two isoforms appeared
to be degraded on mRNA level, presumably via the NMDmechanism. In a previous study in
transgenic mice, it was shown that the critical level of PRPH2 expression required to maintain
the correct morphology and function of rods is about 80% of the native PRPH2 expression
[30]. Thus, the 20% reduction of protein expression induced by the G249Smutation is very
close to this critical level and might be sufficient to cause retinal degeneration in the affected
patient.
Recently, it was shown that mRNA splicing of BBS8, a gene whose defects are associated
with Bardet-Biedl syndrome, is different in rods and cones [32]. This finding and the results of
our study imply that in rods and cones, components of the splicing machinery are dissimilar. It
appears conceivable that cones express a subset of exonic/intronic splice enhancers or silencers
which are not present in rods and vice versa. In accordance with this hypothesis, some known
ESEs (such as SC35 encoded by the SFRS2 gene), but also the ESS hnRNPA1 were found to be
higher expressed on transcript level in rods compared to cones [33] (http://www.fmi.ch/roska.
data/index.php). In addition to the transcript data, a careful analysis of the proteome of rods
and cones could help identifying molecular components which mediate the differential splicing
in rods and cones. Since deletion of intronic regions can also lead to disruption of existing
intronic splice regulatory elements [34, 35], we cannot exclude the possibility that the lack of
the full-length native introns in PRPH2 minigenes used in this study might also affect the
mRNA splicing. The length of the native PRPH2 introns by far exceeds the cloning capacity of
Table 3. Summary of the effects caused by single mutants analyzed in this study.
C214S P210L S198R Q226E W246R G249S V209I R195L R220Q S212T R220W
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viral vectors commonly used for the transduction of photoreceptors. Alternative approaches
for insertion of large transgenes to photoreceptors (i.e. electroporation) are very limited in
terms of their efficiency [13]. However, high efficiency is crucial for expression analysis in
cones, which account for a very small percentage of the photoreceptor population. Thus, from
a technical point of view, the rAAV-mediated gene transfer currently appears the most suitable
method for analysis of splicing and protein expression in photoreceptors.
To our best knowledge, this is the first study showing an experimental design that allows for
the systematic analysis of disease associated point mutations on splicing and on protein expres-
sion in photoreceptors for a single gene. Our results suggest that differential splicing of PRPH2 in
rods and cones might influence the disease mechanisms of single point mutations on transcript
level. Thus, the potential effects of point mutations on splicing in rods and cones might have been
underestimated so far and should be tested for other point mutations in PRPH2 but also for muta-
tions in other genes involved in structural and functional integrity of photoreceptors. Finally, the
differential impact of PRPH2 point mutations on protein expression in outer segments might
help to explain the diverse penetrance of single PRPH2 mutations in rods and cones.
Materials and Methods
Ethics statement
Human post mortem retina samples used in this study originate from organ donors with
explicit informed consent and the approval by the local ethics committee for the use of tissue
for research purposes.
Animals
All procedures concerning animals were performed with permission of local authorities
(Regierung von Oberbayern). Anesthesia was performed by subcutaneous injection of keta-
mine (40mg/kg body weight) and xylazine (20 mg/kg body weight). Euthanasia was performed
by cervical dislocation.
Construction and cloning of the PRPH2 minigenes
To generate the PRPH2 minigenes, three overlapping products containing the DNA-fragments
with full-length exons and shortened PRPH2 introns were PCR amplified from the human
genomic DNA isolated from one of the authors of this study (Elvir Becirovic). The PCR frag-
ments were assembled using the standard overlap PCR techniques and subcloned to the
pcDNA3.1 expression vector (Invitrogen). Subsequently, citrine was subcloned 5’ to exon 1 of
PRPH2. The single PRPH2 point mutants were obtained by site directed mutagenesis (Quik-
Change Lightning Mutagenesis Kit, Agilent Technologies) according to manufacturer’s
instructions. For expression in rods and cones, the single PRPH2 minigenes were subcloned to
the pAAV2/8 vector containing the human rhodopsin (hRHO) or the mouse S-opsin (mSWS)
promoter. Total length of the insert between the inverted terminal repeats (ITRs) including the
promoter, PRPH2 minigene, and the BGH polyA sequence was 4.7 kb for the hRHO promoter
containing vector and 4.4 kb for the pAAV vector bearing the mSWS promoter. All PRPH2
minigenes were completely sequenced prior to use.
In silico prediction of splicing
To predict the splicing of the single PRPH2 point mutants, a free trial ASSEDA splice software
(splice.uwo.ca/) and open access NNSplice (Berkeley Drosophila Genome Project, http://www.
fruitfly.org/seq_tools/splice.html) software were used.
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Splice analysis and quantification of PRPH2 minigene-derived isoforms
in rods and cones
For splice analysis in rods and cones, mice were injected on P14. Three weeks post injection of
the respective PRPH2 minigenes, retinas were scanned for fluorescence by means of fundus
photography (Spectralis, Heidelberg Eye Instruments). Subsequently, four of the dissected fluo-
rescent retinas for each PRPH2 minigene were pooled and used for RNA isolation. The RNA
isolation from injected photoreceptors was performed using the RNeasy Mini Kit (Qiagen)
according to the instructions of the manufacturer. Equal concentrations (1 μg) of the isolated
total RNA from each sample were applied for the subsequent cDNA synthesis (Revert Aid First
Strand cDNA Sythesis Kit, Life Technologies). To amplify the splice isoforms resulting from
the PRPH2 minigenes via PCR, following primers were used:
5’-GGCATGGACGAGCTATACAAG-3‘
5’-GGTTGGACACACCATCCAGCG-3‘
The single PCR products representing the different splice isoforms were extracted, purified,
and sequenced. All experiments in single cell types concerning the total RNA isolation, cDNA
synthesis, and subsequent PCR were performed on the same day under the same conditions.
For semi-quantitative analysis of the single PRPH2 minigenes, five RT-PCR reactions were
conducted using the cDNA described above with variable number of cycles ranging between
25–27 cycles for amplification of PRPH2 minigenes harboring the hRHO promoter, and 30–32
cycles for amplification of PRPH2 minigenes bearing the mSWS promoter, respectively. Statis-
tical analysis was done with one-way ANOVA followed by the Dunett’s test for multiple com-
parisons of the single PRPH2 mutants to the corresponding WT PRPH2 in rods and cones.
The absolute intensities of the single splice bands were determined using the Image Lab soft-
ware (BioRad). The experimental conditions and the type of data analysis for the semi-quanti-
tative RT-PCR analysis of the single PRPH2 minigenes shown in S6 Fig were identical to those
described for Fig 2 except for the number of technical replicates (three in S6 Fig and five in
Fig 2).
rAAV production and subretinal injections
The PRPH2 minigenes were subcloned to the single stranded pAAV2.1 vector containing
either the hRHO or mSWS promoter [36, 37]. Detailed procedures of rAAV production and
subretinal injections were described previously [36]. Titer-matched rAAVs (109 particles/μl)
containing the single PRPH2 minigenes were subretinally injected to WT C57 BL/6J animals
on postnatal day 14. Three weeks post injection, all injected retinas were analyzed for the fluo-
rescence using the scanning laser ophthalmoscopy (Spectralis, Heidelberg Eye Instruments).
Immunohistology and western blotting
For immunohistology, mice were injected at P14 with the respective PRPH2 minigenes. Three
weeks post injection, the retinas were dissected and processed for immunohistology as
described [38]. We used the rabbit anti-CNGB1a (1:2000, [39]) and rabbit anti-M-opsin anti-
body (1:300, [38]) as marker for rod and cone outer segments, respectively. Retinal images
were obtained by the TCS SP8 confocal scan microscope (Leica), acquired with the LASAF
software (Leica), and processed with the ImageJ software (National Institutes of Health). For
protein detection via Western blotting for each of the constructs, we used four pooled retinas
from four mice injected on P14 with the titer-matched PRPH2 minigenes harboring the hRHO
or mSWS promoter. Membrane preparations were performed three weeks post injection as
described [40] and proteins were separated on a 6–12% SDS PAGE gradient gel. To detect the
citrine-tagged proteins, the monoclonal mouse anti-GFP antibody was used (1:1000,
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Clontech). For detection of the Na+/K+ ATPase, we used the mouse anti-a6F-c antibody in a
1:1000 dilution (Developmental Studies Hybridoma Banks, University of Iowa). For semi-
quantitative analysis, three technical replicates were conducted from membrane preparations.
The absolute intensities of the single protein bands were determined using the Image Lab soft-
ware (BioRad). The band intensities for each minigene-derived PRPH2 protein were normal-
ized to the corresponding ATPase intensity.
FAC-sorting of rods and cones
Retinas were isolated from neural retina leucine zipper- (Nrl) EGFP [26] or cone-GFP [27]
reporter mice. In Nrl-EGFP mice, EGFP is driven by the rod-specific Nrl promoter. In cone-
GFP mice, GFP expression is driven by a human red/green opsin gene 5' regulatory sequence.
All animal experiments were conducted in strict accordance with EU and German laws
(Tierschutzgesetz) and the ARVO Statement for the Use of Animals in Ophthalmic and Vision
Research. From each reporter mouse, two retinas were isolated at adult stage (6–8 weeks) and
dissociated using Papain Dissociation System (Worthington Biochemical Corporation, Lake-
wood, USA) for 20 minutes with 100 μg/ml papain following manufacturer’s instructions. Dis-
sociated cells were sorted (BD FACSAria II SORP, BD Bioscience) and cells were collected
based on their reporter fluorescence.
RNA isolation and cDNA synthesis
RNA from FACS purified rod and cone photoreceptors and from native human and murine
retina was extracted using RNeasy Minikit (Qiagen, Hilden, Germany) according to the manu-
facturer’s instructions. RNA concentration and purity was determined using NanoDrop2000
(Thermo Scientific). For cDNA synthesis from native human (two donors) and murine retina
(four animals), an amount of 500 ng total RNA was used. For cDNA synthesis from sorted
murine rods and cones, 50 ng of isolated total RNA was applied.
Quantitative PCR
PCR was performed on a StepOnePlus Real-Time PCR System (Applied Biosystems) using
SYBR Select Master Mix (Applied Biosystems). For quantitative PCR, we performed three tech-
nical replicates for each gene and normalized each of them to the expression of the housekeep-
ing gene aminolevulinic acid synthase (Alas). For detection of the murine transcripts,
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Supporting Information
S1 Fig. Exon 2 specific disease associated point mutations in PRPH2. Left, the region of
PRPH2 encoded by exon 2 is shown as a dashed rectangle. Right, schematic magnification of
the exon 2-encoded part. Currently known positions of point mutations are highlighted in
green. Arrowheads point to the mutations affecting the amino acids analyzed in this study.
Among those, black arrowheads highlight the mutations linked to cone diseases, whereas the
red arrowheads point to the adRP-associated mutations.
(TIF)
S2 Fig. Representative sequence analyses of PRPH2 splice products. (A) Sequencing results
of the exon boundaries from the correctly spliced PRPH2 transcript. Bottom left, topology of
the correctly spliced PRPH2. The region encoded by exon 2 is given as a dashed rectangle. N,
N-terminus, C, C-terminus. (B) Sequencing results of the G249Smutant. Upper panel, scheme
showing the G249Smutant before (top) and after splicing (bottom). Lower panel, left, pre-
dicted impact of the aberrantly spliced G249S on protein level. The generation of a novel splice
donor site (DS) leads to an in-frame deletion of 30 amino acids (aa) covering the part of
PRPH2 symbolized by the brown transparent rectangle. Middle and right, electropherograms
showing the impact of the G249Smutant before and after splicing. The position of the novel
splice donor site is shown as an arrow and the position of the mutation is symbolized by an
arrowhead. (C) Retention of intron 1 and the unspliced PRPH2 transcript result in a frameshift
followed by a stop codon immediately after exon 1. The corresponding protein lacks the distal
half of the D2 loop, the transmembrane domain 4, and the C-terminus (bottom left). All
sequencing reactions were performed on bands isolated from murine retina after viral transfec-
tion with PRPH2 minigenes (Fig 2).
(TIF)
S3 Fig. Determination of the linear amplification range of RT-PCR for PRPH2 minigenes.
Representative qRT-PCR from retinas injected with WT PRPH2 minigenes harboring a rod
hRHO (rP-mg) or cone mSWS (cP-mg) specific promoter. For qRT-PCR, the same pooled ret-
ina samples and the same primers were used as described in Fig 2B. The dashed lines represent
the window of cycles falling within the linear amplification range for rP-mg (20–28 cycles,
magenta) and cP-mg (26–33 cycles, green), respectively.
(TIF)
S4 Fig. Representative fundus photography of murine retinas injected with single PRPH2
minigenes. Fundus photography images were performed three weeks post injection on wild
type mice injected at the age of two weeks with the single PRPH2 minigenes under the control
of a cone specific mSWS (A) or rod specific hRHO (B) promoter. Scale bar represents 800 μm.
(TIF)
S5 Fig. Sum of absolute band intensities for PRPH2 minigenes in rods and cones. The data
shows the total sum of absolute intensities of all bands detected for each PRPH2 minigene
from five technical replicates shown in RT-PCR experiments in Fig 2A. The bars represent the
mean values ± SEM conducted to calculate the relative percentages displayed in Fig 2C–2E. Sta-
tistical analysis (PRPH2 mutants vs the corresponding WT in rods and cones, respectively)
was performed using one-way ANOVA followed by the Dunett’s test. , p< 0.05; , p< 0.01;
, p< 0.001. n.s., not significant.
(TIF)
S6 Fig. Cross-expression of one rod-dominant PRPH2 mutant in cones and one cone-dom-
inant mutant in rods. Protein localization (A, F), mRNA splicing (B, C, G, H), and protein
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expression (D, E, I, J) of a cone dominant R220Wmutation in rods (A-E) and a rod-dominant
W246Rmutation in cones (F-J). The experimental conditions (age of injected mice, immunola-
beling of retinal sections, time point of RNA isolation, number of cycles used for the RT-PCR,
number of injected animals, time point of protein isolation, type of data presentation) are iden-
tical to those described for the corresponding experiments in Figs 1, 2, 5 and 6. For semi-quan-
titative analysis of mRNA splicing (C, H) and protein expression (E, J) in rods and cones,
three technical replicates were conducted. Statistics were calculated using the two-tailed t-test.
p-values shown in C, H, E, and J are as follows: C, punspliced = 0.91, pcorrectly spliced = 0.76; H,
punspliced = 0.74, pcorrectly spliced = 0.87; E, p = 0.39; J, p = 0.25. Scale bar in A, F represents 20 μm.
(TIF)
S1 Table. In silico splice analysis of 30 point mutations in exon 2 of PRPH2. For splice anal-
ysis using ASSEDA prediction software, 40 bp flanking the respective mutation were used. All
changes for single splice elements or donor and acceptor sites are shown as fold changes to the
WT. For NNSplice based prediction, single scores are given for the WT PRPH2 and changes to
this score for the mutants are highlighted in blue. " or #, increase or decrease of the score for a
given recognition sequence or for a donor and acceptor site, respectively. The numbers next to
these symbols represent the fold change to the WT. AS, splice acceptor site, DS, splice donor
site, n.c., no change. The position of the respective splice acceptor or donor site (AG and GT,
respectively) within the given DNA-sequence is shown in red. SF2/ASF, SC35, SRp40 und
SRp55, serine/arginine (SR)-rich proteins belonging to the exonic splice enhancer (ESE).
hnRNPA1, proteins belonging to the exonic splice silencer (ESS). Both, abolition of the consen-
sus sequence of ESEs or generation of a novel recognition sequence for ESS, might lead to exon
skipping or intron retention.
(XLSX)
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